Let us know what you think...
Only logged in customers who have purchased this product may leave a review. Log in now
APRICON/APRICON 750 contains 100 percent of apricot kernels rich in Vitamin B17, also known as Amygdalin or Laetrile.
It will be finely ground after undergoing UV radiation to get rid of bacteria, fungi and radicals.
Vitamin B17 will improve the immune system and body resistance towards various diseases improve the fitness and health of the individual.
Vitamin B17 Amygdalin component and function as a natural chemotherapy agent that is capable of controlling the growth of abnormal cells that are not controlled effectively.
Based on scientific studies and clinical trials that was conducted previously, Vitamin B17 or Amygdalin able to cure and treat the metabolic system and stabilize the body systems that functioning abnormally.
The effectiveness of Vitamin B17 in treating and preventing various chronic diseases has been clearly proven and recognized by the medical practitioner.
Among the benefits of Vitamin B17 include:
• Prevent and control abnormal cell growth (benign and malignant) which grew uncontrollable in the part of the brain, cervical, breast, liver, bone, uterus, stomach, prostate, ovarian, lung, colon, skin and others;
• Regulate blood sugar levels, stabilize blood pressure and reduce cholesterol in heart;
• Helps to treat gout and rheumatism;
• Clean arteries by reducing cholesterol levels;
• Helps to treat gout and rheumatism;
• Clean arteries by reducing cholesterol levels;
• Helps in respiratory problems;
• Help with hemorrhoids (indigestion / excretion);
• Acts as a tonic and antioxidants that can eliminate toxins in the body;
• Help speed up the process of wound healing;
• Regulate irregular menstruation and vaginal discharge; and
• Treat skin problems like rashes and allergies.
Suggestion of intake (Adult): takes 2 capsule 2 times a day before or after meal.
Only logged in customers who have purchased this product may leave a review. Log in now
What others are saying
There are no contributions yet.